Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Consumer Discretionary›Consumer Services›Leisure Services
NSE:JSLL

JEENA SIKHO LIFECARE LTD

Consumer Services › Leisure Services·NIFTY MICROCAP 250NIFTY SMALLCAP 500NIFTY TOTAL MARKET
₹347.80
at close · 28 Oct 2026
▲ 2.80 (+0.81%)

Latest filings

  1. Allotment of 23,374 equity shares under ESOS 2024 · Capital Market Events
  2. Compliance certificate under SEBI Regulation 74(5) for September 2026 quarter · Compliance
  3. Jeena Sikho launches 8 new Ayurvedic and nutraceutical products · Business Updates
All filings ↓
Ask Nexa about JEENA SIKHO LIFECARE LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates a hub-and-spoke network of Ayurvedic hospitals and sells Ayurvedic medicines and OTC wellness products. The Healthcare Services segment, which runs inpatient, outpatient, daycare and virtual-OPD treatments across hospitals, contributed 47.8% of FY26 revenue (₹383.4 crore). The Ayurvedic Products and Medicines segment, which makes and sells items like the Entero and NutriRoz OTC lines plus new pain-relief patches, contributed 51.9% (₹415.7 crore). Distribution for OTC products is being scaled through an Entero partnership that gives access to 1.25 lakh of India's 9 lakh chemists. Diagnostics inside the hospitals are run through a partnership with Chandan, currently at 34 centres generating ₹3 lakh/day and scaling to 64. Expansion includes 2,700-2,800 beds under development toward a 7,000-10,000 bed target over 3-5 years, plus international operations in UAE, Kazakhstan and Nepal. Other operating expenses (26.5% of revenue) and employee costs (18.5%) are the largest disclosed cost lines; materials cost is reported at 0.0% of revenue.

Revenue mix · reported segments
Ayurvedic Products and Medicines51.9%
Ayurvedic Healthcare Services47.8%
Others0.3%
Operating scale
Operational beds
2,290Q3 FY26
Beds under development
2,700-2,800Q3 FY26
Bed target (3-5 years)
7,000-10,000FY26
Chandan diagnostics centres
34, scaling to 64Q3 FY26
Chandan diagnostics revenue
₹3 lakh/day (target ₹5 lakh/day)Q3 FY26
OTC chemist reach via Entero
1.25 lakh of India's 9 lakh chemistsQ3 FY26
Who pays it
Patients seeking Ayurvedic treatment (IPD, OPD, daycare, virtual OPD), retail consumers buying OTC products, and chemists/pharmacies stocking the OTC range.
Biggest cost
Other operating expenses at 26.5% of revenue, followed by employee costs at 18.5% of revenue.
Kind of business
Asset-light, capital-light expansion of an Ayurvedic hospital chain and OTC wellness products franchise.
Where it sits
Hub-and-spoke Ayurvedic hospital operator with 2,290 operational beds against an estimated 20 lakh total hospital beds in India (9 lakh government, 11 lakh private).
Market Cap
₹4,323 Cr
P / E (TTM)
18.3×
EV / EBITDA
11.2×
Div Yield
0.32%
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
54.5%▲
ROCE (FY26)
ROE 47.5% · margin 44.7%
Leverage
0.00·
Debt / Equity · low
Net cash ₹16 Cr
Moves on a normal day
1.70%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 103 Leisure Services peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#31/87
P/B#74/83
ROCE#4/101
ROE#2/83
Debt / Equity#17/82
EBITDA margin#14/85
Revenue growth#15/89
Profit growth#37/83

Scorecard

Measured from the filed financials, judged against its Leisure Services peers · as of FY26 — not investment advice

Strengths
Returns on capital 54.5%
#4 of 101 in Leisure Services on the latest reported figures
Debt at 0.00× equity
lower than 79% of its 82 Leisure Services peers
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

JSLL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from JEENA SIKHO LIFECARE LTD's filed financials and exchange disclosures

What does JEENA SIKHO LIFECARE LTD do?

JEENA SIKHO LIFECARE LTD is a Leisure Services company listed on NSE and BSE, trading under the symbol JSLL.

Is JEENA SIKHO LIFECARE LTD profitable?

Yes. Over the trailing twelve months JEENA SIKHO LIFECARE LTD reported a net profit of ₹236 Cr on revenue of ₹851 Cr.

Does JEENA SIKHO LIFECARE LTD pay a dividend?

Yes. The dividend yield is 0.32% at the current price. It paid out 6% of its profit as dividend in FY26.

Is JEENA SIKHO LIFECARE LTD debt-free?

On a net basis, yes. It reported borrowings of ₹0.45 Cr on its 31 Mar 2026 balance sheet, but holds ₹16 Cr more cash than debt.

Is JEENA SIKHO LIFECARE LTD expensive compared with its peers?

On trailing P/E, JEENA SIKHO LIFECARE LTD ranks 31 of 87 in Leisure Services — cheaper than 65% of them, against an industry median of 26.6×. This is a position, not a valuation judgement.

How much does the JEENA SIKHO LIFECARE LTD share price move in a day?

On a typical session JEENA SIKHO LIFECARE LTD moves 1.70% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

Where can I track JEENA SIKHO LIFECARE LTD's announcements?

Every NSE and BSE filing by JEENA SIKHO LIFECARE LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.